1. LungenClinic Grosshansdorf, Grosshansdorf, Germany;
2. Christian Albrechts University of Kiel, Kiel, Germany;
3. Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany;
4. Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska;
5. NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York;
6. Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, Massachusetts;
7. Harvard Medical School, Boston, Massachusetts;
8. Medicines Evaluation Unit, Manchester University National Health Service Foundation Trust, University of Manchester, Manchester, United Kingdom;
9. Respiratory Medicine, Department of Translational Medicine, University of Ferrara, Ferrara, Italy;
10. School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, United Kingdom;
11. Sanofi, Bridgewater, New Jersey; and
12. Regeneron Pharmaceuticals Inc., Tarrytown, New York